Clinical Trial

Safety and Efficacy of KER-065 in Participants With Duchenne Muscular Dystrophy

Name: Safety and Efficacy of KER-065 in Participants With Duchenne Muscular Dystrophy — clinical trial record (NCT07704099)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and efficacy of KER-065 administered to adult and pediatric ambulatory and nonambulatory male participants with Duchenne Muscular Dystrophy (DMD) on stable background therapy.

Trial Details

NCT Number	NCT07704099
Lead Sponsor	Keros Therapeutics, Inc.
Conditions	Duchenne Muscular Dystrophy
Enrollment	36 participants
Start Date	2026-09-14
Primary Completion	2029-07-17 (estimated)
Study Completion	2029-08-14 (estimated)
Updated on ClinicalTrials.gov	2026-08-10